SCHEMBL625824

SCHEMBL625824

CSc1nccnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29379769 1.00
SCHEMBL17153734 0.78
SCHEMBL10847325 0.74
SCHEMBL67391 0.71
SCHEMBL31293666 0.69
SCHEMBL20339880 0.69
Iodide SCHEMBL6774372 0.69
SCHEMBL30209598 0.65
SCHEMBL676558 0.63
SCHEMBL30267304 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115787007-A Acidic sulfate electronic copper electroplating additive composition and application thereof 厦门大学 2023-03-14 CN claimed
CN-113337857-B Acidic sulfate copper electroplating combined additive for thickening PCB through hole metal 厦门大学 2022-06-21 CN claimed
CN-114133377-A Quinoline-1, 2, 4-triazine heterozygote, and preparation method and application thereof 江苏海洋大学 2022-03-04 CN claimed
CN-113337857-A Acidic sulfate copper electroplating combined additive for thickening PCB through hole metal 厦门大学 2021-09-03 CN claimed
EP-4568746-B1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2026-04-29 EP disclosed
EP-4695231-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics Inc. (US) 2026-02-18 EP disclosed
EP-4634158-A2 INHIBITORS OF PROCASPASE-6 ACTIVATION AND USES THEREOF The Regents of University of California (US) 2025-10-22 EP disclosed
US-20250236617-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2025-07-24 US disclosed
EP-4568746-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-06-18 EP disclosed
US-20250152584-A1 NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF TRANSTHERA SCIENCES (NANJING), INC. (CN) 2025-05-15 US disclosed
EP-4461729-A1 ANTIGEN BINDING PROTEIN TARGETING MSLN AND USE THEREOF Transthera Sciences (Nanjing), Inc. (CN) 2024-11-13 EP disclosed
WO-2024216209-A1 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2024-10-17 WO disclosed
EP-0007687-B1 SULFONAMIDES, PROCESSES FOR THEIR PREPARATION, COMPOSITIONS CONTAINING SAID SULFONAMIDES AND A METHOD FOR CONTROLLING THE GROWTH OF VEGETATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-03-30 EP disclosed
WO-1983000864-A1 ANTIINFLAMMATORY SUBSTITUTED-1,2,4-TRIAZOLOAD4,3-bBD-1,2,4-TRIAZINES DIAMOND SHAMROCK CORP (US) 1983-03-17 WO disclosed
US-4310551-A Pharmacologically active substituted 1,2,4-triazines DIAMOND SHAMROCK CORPORATION (US) 1982-01-12 US disclosed
US-4251527-A ANTIINFLAMMATORY AGENTS DIAMOND SHAMROCK CORPORATION (US) 1981-02-17 US disclosed
US-4215121-A Pyrazine substituted ureas MERCK & CO., INC. (US) 1980-07-29 US disclosed
US-4157392-A HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS AND NERVOUS SYSTEM EFFECTS DIAMOND SHAMROCK CORPORATION (US) 1979-06-05 US disclosed
US-4144338-A N-pyrimidinyl-N-dialkylaminoalkyl ureas MERCK & CO., INC. (US) 1979-03-13 US disclosed
US-4105434-A Herbicidal 5,5'-bis-1,2,4-triazinyls DIAMOND SHAMROCK CORPORATION (US) 1978-08-08 US disclosed